The relationship between NAFLD with diet and exercise: Current perspectives

Document Type : Review Articles

Author

Department of Exercise Physiology, Karaj Branch, Islamic Azad University, Karaj, Iran.

Abstract

NAFLD, a general term that describes several diseases caused by hepatic fat deposition such as hepatic steatosis (HS) and nonalcoholic steatohepatitis (NASH), includes the many conditions that are related to fat accumulation in the liver. Indeed, NAFLD is treated with a treatment plan consisting of weight loss, nutritional supplementation, and physical activity. Despite the lack of scientific research on diet and physical exercise, there is a paucity of evidence on NAFLD. The DASH and Mediterranean diets have been frequently used for treating cardiovascular metabolic risk factors, such as insulin resistance and type 2 diabetes mellitus (T2DM). In this study, an in-depth assessment of existing dietary and physical activity methods, involving Brazilian and other country-specific recommendations was conducted to determine their effect on the risk of nonalcoholic fatty liver disease (NAFLD).

What is already known on this subject?

NAFLD, a general term that describes several diseases caused by hepatic fat deposition such as hepatic steatosis (HS) and nonalcoholic steatohepatitis (NASH), includes the many conditions that are related to fat accumulation in the liver.

 

What this study adds?

Although exercise has significant cardiovascular advantages, it is likely that the most beneficial use of exercise will be in conjunction with dietary changes, whether in NAFLD or NASH. Taken altogether, this data shows the critical nature of lifestyle modification as the main treatment for NAFLD, NASH, and other chronic illnesses. Instead of arguing whether lifestyle modification is a successful clinical treatment approach, the issue now is how to incorporate it into routine clinical care.

Keywords

Main Subjects

References

Abdul-Hai, A., Abdallah, A., & Malnick, S. D. (2015). Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World Journal of Hepatology, 7(12), 1679. doi: https://doi.org/10.4254/wjh.v7.i12.1679
Aguirre, L., Portillo, M. P., Hijona, E., & Bujanda, L. (2014). Effects of resveratrol and other polyphenols in hepatic steatosis. World Journal of Gastroenterology: WJG, 20(23), 7366. doi: https://doi.org/10.3748/wjg.v20.i23.7366
Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., . . . Day, C. (2005). Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut, 54(7), 987-993. doi: http://dx.doi.org/10.1136/gut.2004.057968
Allen, A. M., Therneau, T. M., Larson, J. J., Coward, A., Somers, V. K., & Kamath, P. S. (2018). Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year‐community study. Hepatology, 67(5), 1726-1736. URL: https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.29546
Attar, B. M., & Van Thiel, D. H. (2013). Current concepts and management approaches in nonalcoholic fatty liver disease. The Scientific World Journal, 2013. doi: https://doi.org/10.1155/2013/481893
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010). Epidemiology of non-alcoholic fatty liver disease. Digestive Diseases, 28(1), 155-161. doi: https://doi.org/10.1159/000282080
Bozzetto, L., Prinster, A., Annuzzi, G., Costagliola, L., Mangione, A., Vitelli, A., . . . Vigorito, C. (2012). Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes care, 35(7), 1429-1435. doi: https://doi.org/10.2337/dc12-0033
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999). Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. The American Journal of Gastroenterology, 94(9), 2467-2474. doi: https://doi.org/10.1016/S0002-9270(99)00433-5
Buss, C., Valle-Tovo, C., Miozzo, S., & de Mattos, A. A. (2015). Probiotics and synbiotics may improve liver aminotransferases levels  in non-alcoholic fatty liver disease patients. Annals of Hepatology,13(5), 482-488. doi: https://doi.org/10.1016/S1665-2681(19)31246-3
Chai, J. W., Lin, Y. C., Chen, J. H., Wu, C. C., Lee, C. P., Chu, W. C., & Lee, S. K. (2001). In vivo magnetic resonance (MR) study of fatty liver: importance of intracellular ultrastructural alteration for MR tissue parameters change. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine, 14(1), 35-41. doi: https://doi.org/10.1002/jmri.1148
Chen, S., Zhao, X., Ran, L., Wan, J., Wang, X., Qin, Y., . . . Zhang, Q. (2015). Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Digestive and Liver Disease, 47(3), 226-232. doi: https://doi.org/10.1016/j.dld.2014.11.015
Chung, M., Ma, J., Patel, K., Berger, S., Lau, J., & Lichtenstein, A. H. (2014). Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. The American Journal of Clinical Nutrition, 100(3), 833-849. doi: https://doi.org/10.3945/ajcn.114.086314
Cleveland, E., Bandy, A., & VanWagner, L. B. (2018). Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Clinical Liver Disease, 11(4), 98. doi: https://doi.org/10.1002/cld.716
Dai, W., Ye, L., Liu, A., Wen, S. W., Deng, J., Wu, X., & Lai, Z. (2017). Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine, 96(39). doi: https://doi.org/10.1097/MD.0000000000008179
De Backer, G., Jankowski, P., Kotseva, K., Mirrakhimov, E., Reiner, Ž., Rydén, L., . . . De Backer, G. (2019). Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis, 285, 135-146. doi: https://doi.org/10.1016/j.atherosclerosis.2019.03.014
Duarte, S. M. B., Faintuch, J., Stefano, J. T., de Oliveira, M. B. S., de Campos Mazo, D. F., Rabelo, F., . . . de Oliveira, C. P. M. S. (2014). Hypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD). Nutricion Hospitalaria, 29(1), 94-101. URL: https://www.redalyc.org/pdf/3092/309231665013.pdf
Dunn, W., Sanyal, A. J., Brunt, E. M., Unalp-Arida, A., Donohue, M., McCullough, A. J., & Schwimmer, J. B. (2012). Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). Journal of Hepatology, 57(2), 384-391. doi: https://doi.org/10.1016/j.jhep.2012.03.024
Dvorak, K., Hainer, R., Petrtyl, J., Zeman, M., Vareka, T., Zak, A., . . . Bruha, R. (2015). The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic. Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 159(3).  URL: https://biomed.papers.upol.cz/pdfs/bio/2015/03/18.pdf
Faghihzadeh, F., Adibi, P., Rafiei, R., & Hekmatdoost, A. (2014). Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutrition Research, 34(10), 837-843. doi: https://doi.org/10.1016/j.nutres.2014.09.005
Farrell, G. C., & Larter, C. Z. (2006). Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology, 43(S1), S99-S112. URL: https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.20973
Georgoulis, M., Fragopoulou, E., Kontogianni, M. D., Margariti, A., Boulamatsi, O., Detopoulou, P., . . . Papatheodoridis, G. (2015). Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity. Nutrition Research, 35(1), 41-48. doi: https://doi.org/10.1016/j.nutres.2014.11.004
Gunji, T., Matsuhashi, N., Sato, H., Fujibayashi, K., Okumura, M., Sasabe, N., & Urabe, A. (2009). Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Official journal of the American College of Gastroenterology| ACG, 104(9), 2189-2195.
Hu, T., Mills, K. T., Yao, L., Demanelis, K., Eloustaz, M., Yancy Jr, W. S., . . . Bazzano, L. A. (2012). Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. American Journal of Epidemiology, 176(suppl_7), S44-S54. doi: https://doi.org/10.1093/aje/kws264
Inzucchi, S. E., Bergenstal, R., Buse, J., Diamant, M., Ferrannini, E., Nauck, M., . . . Matthews, D. (2012). Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia, 55(6), 1577-1596. doi: https://doi.org/10.1007/s00125-012-2534-0
Jackson-Leach, R., & Lobstein, T. (2006). Estimated burden of paediatric obesity and co-morbidities in Europe. Part 1. The increase in the prevalence of child obesity in Europe is itself increasing. International Journal of Pediatric Obesity, 1(1), 26-32.  URL: https://www.tandfonline.com/doi/abs/10.1080/17477160600586614
Ji, H.-F., Sun, Y., & Shen, L. (2014). Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis. Nutrition, 30(9), 986-991. doi: https://doi.org/10.1016/j.nut.2014.01.016
Jia, Q., Xia, Y., Zhang, Q., Wu, H., Du, H., Liu, L., . . . Liu, X. (2015). Dietary patterns are associated with prevalence of fatty liver disease in adults. European Journal of Clinical Nutrition, 69(8), 914-921. doi: https://doi.org/10.1038/ejcn.2014.297
Jiang, X.-C., Li, Z., Liu, R., Yang, X. P., Pan, M., Lagrost, L., . . . Williams, K. J. (2005). Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. Journal of Biological Chemistry, 280(18), 18336-18340.  doi: https://doi.org/10.1074/jbc.M500007200
Jiang, X., Zhang, D., & Jiang, W. (2014). Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. European Journal of Nutrition, 53(1), 25-38. doi: https://doi.org/10.1007/s00394-013-0603-x
Kikuchi, L., Oliveira, C. P., & Carrilho, F. J. (2014). Nonalcoholic fatty liver disease and hepatocellular carcinoma. BioMed Research International, 2014. doi: https://doi.org/10.1155/2014/106247
Kwok, R., Choi, K. C., Wong, G. L.-H., Zhang, Y., Chan, H. L.-Y., Luk, A. O.-Y., . . . Chan, J. C.-N. (2016). Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut, 65(8), 1359-1368. doi: http://dx.doi.org/10.1136/gutjnl-2015-309265
Leite, N. C., Villela-Nogueira, C. A., Cardoso, C. R., & Salles, G. F. (2014). Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. World Journal of Gastroenterology: WJG, 20(26), 8377. doi: http://dx.doi.org/10.1136/gutjnl-2015-309265
Ma, Y.-Y., Li, L., Yu, C.-H., Shen, Z., Chen, L.-H., & Li, Y.-M. (2013). Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World Journal of Gastroenterology: WJG, 19(40), 6911. doi: http://dx.doi.org/10.3748/wjg.v19.i40.6911
Marchesini, G., Petta, S., & Dalle Grave, R. (2016). Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice. Hepatology, 63(6), 2032-2043.  URL: https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.28392
Masarone, M., Federico, A., Abenavoli, L., Loguercio, C., & Persico, M. (2014). Non alcoholic fatty liver: epidemiology and natural history. Reviews on Recent Clinical Trials, 9(3), 126-133.
McCarthy, E. M., & Rinella, M. E. (2012). The role of diet and nutrient composition in nonalcoholic fatty liver disease. Journal of the Academy of Nutrition and Dietetics, 112(3), 401-409. doi: https://doi.org/10.1016/j.jada.2011.10.007
McKay, A., Wilman, H. R., Dennis, A., Kelly, M., Gyngell, M. L., Neubauer, S., . . . Thomas, E. L. (2018). Measurement of liver iron by magnetic resonance imaging in the UK Biobank population. PloS one, 13(12), e0209340. doi: https://doi.org/10.1371/journal.pone.0209340
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., . . . Perotti, G. (2009). Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology, 49(6), 1877-1887.
Moschen, A. R., & Tilg, H. (2008). Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition & Metabolic Care, 11(5), 620-625. doi: https://doi.org/10.1097/MCO.0b013e32830b5d09
Nabavi, S., Rafraf, M., Somi, M., Homayouni-Rad, A., & Asghari-Jafarabadi, M. (2014). Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. Journal of Dairy Science, 97(12), 7386-7393. doi: https://doi.org/10.3168/jds.2014-8500
Oliveira, C. P., da Costa Gayotto, L. C., Tatai, C., Della Bina, B. I., Janiszewski, M., Lima, E., . . . Laudanna, A. (2002). Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline‐deficient diet. Journal of Cellular and Molecular Medicine, 6(3), 399-406. doi: https://doi.org/10.1111/j.1582-4934.2002.tb00518.x
Oliveira, C. P., de Lima Sanches, P., de Abreu-Silva, E. O., & Marcadenti, A. (2016). Nutrition and physical activity in nonalcoholic fatty liver disease. Journal of Diabetes Research, 2016.  doi: https://doi.org/10.1155/2016/4597246
Portillo-Sanchez, P., Bril, F., Maximos, M., Lomonaco, R., Biernacki, D., Orsak, B., . . . Cusi, K. (2015). High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. The Journal of Clinical Endocrinology & Metabolism, 100(6), 2231-2238. doi: https://doi.org/10.1210/jc.2015-1966
Santos, R. D., Gagliardi, A., Xavier, H., Magnoni, C., Cassani, R., Lottenberg, A., . . . Alves, R. (2013). I Diretriz sobre o consumo de gorduras e saúde cardiovascular. Arquivos Brasileiros de Cardiologia, 100(1), 1-40. doi: https://doi.org/10.1590/S0066-782X2013000900001
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., . . . Unalp, A. (2010). Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. New England Journal of Medicine, 362(18), 1675-1685. doi: https://doi.org/10.1056/NEJMoa0907929
Schugar, R. C., & Crawford, P. A. (2012). Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition and Metabolic Care, 15(4), 374. doi: https://doi.org/10.1097/MCO.0b013e3283547157
Seitz, H. K., Mueller, S., Hellerbrand, C., & Liangpunsakul, S. (2015). Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD). Hepatobiliary Surgery and Nutrition, 4(3), 147. doi: https://doi.org/10.3978/j.issn.2304-3881.2014.12.01
Shaikh, R. S., Patil, P., & Lathia, T. (2019). Implications of Metabolically Healthy Obesity—Ganesha Speaks. Journal of Social Health and Diabetes, 7(02), 87-88.
Sookoian, S., Castaño, G. O., & Pirola, C. J. (2014). Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals. Gut, 63(3), 530-532. doi: http://dx.doi.org/10.1136/gutjnl-2013-305718
Suzuki, A., Angulo, P., Sauver, J. S., Muto, A., Okada, T., & Lindor, K. (2007). Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Official Journal of the American College of Gastroenterology| ACG, 102(9), 1912-1919. doi: http://dx.doi.org/10.1055/s-0039-3402538
Velasco, N., Contreras, A., & Grassi, B. (2014). The Mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition & Metabolic Care, 17(5), 453-457. doi: https://doi.org/10.1097/MCO.0000000000000071
Westerbacka, J., Lammi, K., Häkkinen, A.-M., Rissanen, A., Salminen, I., Aro, A., & Yki-Järvinen, H. (2005). Dietary fat content modifies liver fat in overweight nondiabetic subjects. The Journal of Clinical Endocrinology & Metabolism, 90(5), 2804-2809. doi: https://doi.org/10.1210/jc.2004-1983
Williamson, R. M., Price, J. F., Glancy, S., Perry, E., Nee, L. D., Hayes, P. C., . . . Reynolds, R. M. (2011). Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care, 34(5), 1139-1144. doi: https://doi.org/10.1210/jc.2004-1983
Zamara, E., Novo, E., Marra, F., Gentilini, A., Romanelli, R. G., Caligiuri, A., . . Danni, O. (2004). 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. Journal of Hepatology, 40(1), 60-68. doi: https://doi.org/10.1016/S0168-8278(03)00480-X
Zivkovic, A. M., German, J. B., & Sanyal, A. J. (2007). Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. The American Journal of Clinical Nutrition, 86(2), 285-300. doi: https://doi.org/10.1093/ajcn/86.2.285
 
Journal of Exercise & Organ Cross Talk
Volume 2, Issue 4
December 2022
Pages 161-167

Files

History

  • Receive Date: 30 September 2022
  • Revise Date: 01 December 2022
  • Accept Date: 08 December 2022

Share

How to cite

Statistics